Tru Niagen®, Consumer Product was Niagen Bioscience’s largest segment in fiscal 2025, bringing in $97.67M of $227.88M (43%).
| Subsegments | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Tru Niagen®, Consumer Product | $60.11M | $69.53M | $76.77M | $97.67M | ||||
| Subtotal Niagen® Related | $60.11M | $69.53M | $76.77M | $97.67M | ||||
| Tru Niagen Consumer Product | — | — | — | — | ||||
| Niagen Related | — | — | — | — | ||||
| Food-Grade Niagen® | — | $10.55M | $17.54M | $24.11M | ||||
| Niagen Ingredient | — | — | — | — | ||||
| Subtotal Other Goods & Services | $6.86M | $587.00K | $574.00K | $781.00K | ||||
| Other Goods & Services | — | — | — | — | ||||
| Reference Standards | $3.08M | $2.80M | $2.89M | $3.00M | ||||
| Pharmaceutical-Grade Niagen® | — | — | $1.70M | $3.78M | ||||
| Other Ingredients | $456.00K | $587.00K | $574.00K | $781.00K | ||||
| Consulting & Other | $123.00K | $101.00K | $120.00K | $73.00K | ||||
| Total | $130.74M | $153.69M | $176.94M | $227.88M |
Niagen Bioscience brought in $227.88M from its eight segments in fiscal 2025, the year ended December 31, 2025. That was up 28.8% from $176.94M in fiscal 2024. Tru Niagen®, Consumer Product was the largest at $97.67M (42.9%), ahead of Subtotal Niagen® Related at $97.67M (42.9%) and Food-Grade Niagen® at $24.11M (10.6%). The other five segments brought in $8.42M combined.
Compared with fiscal 2024, Food-Grade Niagen® grew fastest, up 37.5% to $24.11M. Every segment above 2% of revenue grew.
Niagen Bioscience began breaking out Food-Grade Niagen® in fiscal 2023 and Pharmaceutical-Grade Niagen® in fiscal 2024.
Consumer Products Segment was Niagen Bioscience’s largest segment in fiscal 2025, bringing in $97.67M of $124.79M (78%).
| Segment | FY 2011 | FY 2012 | FY 2013 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Products Segment | $60.11M | $69.53M | $76.77M | $97.67M | ||||||||||
| Consumer Products | — | — | — | — | ||||||||||
| Ingredients Segment | $8.74M | $10.55M | $17.54M | $24.11M | ||||||||||
| Ingredients | — | — | — | — | ||||||||||
| Core Standards Contract Service & Ingredients | — | — | — | — | ||||||||||
| Core Standards Contract Services | — | — | — | — | ||||||||||
| Corestandardscontractservices | — | — | — | — | ||||||||||
| Scientific Regulatory | — | — | — | — | ||||||||||
| Analytical Reference Standards & Services Segment | $3.08M | $2.80M | $2.89M | $3.00M | ||||||||||
| Analytical Reference Standards & Services | — | — | — | — | ||||||||||
| Scientific & Regulatory Consulting Segment | — | — | — | — | ||||||||||
| Scientificregulatory | — | — | — | — | ||||||||||
| Retai Ldietary Supplement Products1 | — | — | — | — | ||||||||||
| Other | — | — | — | — | ||||||||||
| Total | $71.93M | $82.88M | $97.20M | $124.79M |
Niagen Bioscience brought in $124.79M from its three segments in fiscal 2025, the year ended December 31, 2025. That is less than the $227.88M it reports by subsegments, so these segments do not cover all of its revenue. Consumer Products Segment was the largest at $97.67M (78.3%), ahead of Ingredients Segment at $24.11M (19.3%) and Analytical Reference Standards & Services Segment at $3.00M (2.4%).
Compared with fiscal 2024, Ingredients Segment grew fastest, up 37.5% to $24.11M. Every segment above 2% of revenue grew.
Niagen Bioscience (NAGE) reports its revenue by subsegments and by segment. In fiscal 2025, Tru Niagen®, Consumer Product was its largest segment, bringing in $97.67M (42.9% of the total), followed by Subtotal Niagen® Related at $97.67M (42.9%).
Tru Niagen®, Consumer Product was Niagen Bioscience's largest segment in fiscal 2025, bringing in $97.67M, or 42.9% of the $227.88M total across its eight segments.
Among Niagen Bioscience's segments that make up at least 2% of revenue, Food-Grade Niagen® grew fastest in fiscal 2025, up 37.5% from $17.54M to $24.11M.
Every figure comes from Niagen Bioscience's annual financial filings, as reported. Each line keeps the name Niagen Bioscience gives it, and years follow its fiscal calendar.
Niagen Bioscience's revenue by subsegments goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.